Rifaximin (Xifaxan) for travelers' diarrhea

Medical Letter on Drugs and Therapeutics

Volumn 46, Issue 1191, 2004, Pages 74-75

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; RIFAMYCIN; RIFAXIMIN;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIARRHEA; DRUG INTERACTION; HUMAN; RANDOMIZED CONTROLLED TRIAL; TRAVEL;

ANTI-INFECTIVE AGENTS; DIARRHEA; DRUG INTERACTIONS; HUMANS; RANDOMIZED CONTROLLED TRIALS; RIFAMYCINS; TRAVEL;

EID: 5044250607     PISSN: 0025732X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (5)

1. R Steffen et al. Travelers' diarrhea in the new millennium: consen sus among experts from German-speaking countries. J Travel Med 2003; 10:38.
2. JM Sierra et al. In vitro activity of rifaximin against enteropathogen enteropathogens producing traveler's diarrhea. Antimicrob Agents Chemother 2001; 45:643.
3. R Steffen et al. Therapy of travelers' diarrhea with rifaximin on various continents. Am J Gastroenterol 2003; 98:1073.
4. HL DuPont et al. Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: a randomized, double-blind clinical trial. Clin Infect Dis 2001; 33:1807.
5. HL Dupont et al. Rifaximin, a non-absorbed antibiotic prevents travelers' diarrhea. Presented at Digestive Disease Week, New Orleans, LA, May 2004; abstract 94.